Search

Your search keyword '"Rustamova, Yasmin"' showing total 21 results
Start Over Author "Rustamova, Yasmin"
21 results on '"Rustamova, Yasmin"'

1. Cardiac Amyloidosis Screening and Management in Patients With Heart Failure With Preserved Ejection Fraction: An International Survey

Author

Shchendrygina, Anastasia, Mewton, Nathan, Niederseer, David, Kida, Keisuke, Guidetti, Federica, Duval, Antoine Jobbe, Milinkovic, Ivan, Oerlemans, Marish I.F.J., Zaleska-Kociecka, Marta, de Gracia, Sydney Goldfeder, Palacio, Maria Isabel, Giverts, Ilya, Komarova, Irina, Rustamova, Yasmin, Bahouth, Fadel, Mežnar, Anja Zupan, Mapelli, Massimo, Suvorov, Alexandr, Dyachuk, Irina, Shutov, Michail, Sitnikova, Violetta, Garnier-Crussard, Antoine, Barasa, Anders, Loncar, Goran, Tokmakova, Mariya, Skouri, Hadi, Ruschitzka, Frank, and Saldarriaga, Clara

Published
2025
Full Text
View/download PDF

2. Diagnostic and therapeutic practice for Heart Failure with preserved ejection fraction around the world: An international survey

Author

Saldarriaga, Clara, de Gracia, Sydney Stephanie Goldfeder, Mejia, Maria Isabel Palacio, Shchendrygina, Anastasia, Kida, Keisuke, Fauvel, Charles, Zaleska-Kociecka, Marta, Mapelli, Massimo, Einarsson, Hafsteinn, Guidetti, Federica, Robledo, Gina Gonzalez, Milinkovic, Ivan, Esperon, Guillermina, Tejero, Alberto, Meznar, Anja Zupan, Rustamova, Yasmin, Vishram-Nielsen, Julie, Mohty, Dania, Zieroth, Shelley, Barasa, Anders, Ingimarsdóttir, Inga Jóna, Tun, Han Naung, Tham, Novi, Rakotonoel, Rolland, Rosano, Giuseppe M.C., Ruschitzka, Frank, and Mewton, Nathan

Published
2024
Full Text
View/download PDF

3. Miscellanea

Author

Rustamova, Yasmin, Lombardi, Massimo, Rustamova, Yasmin, and Lombardi, Massimo

Published
2020
Full Text
View/download PDF

15. 2021 ESC/EACTS Guidelines for the management of valvular heart disease

Author

Vahanian, Alec, Beyersdorf, Friedhelm, Praz, Fabien, Milojevic, Milan, Baldus, Stephan, Bauersachs, Johann, Capodanno, Davide, Conradi, Lenard, de Bonis, Michele, de Paulis, Ruggero, Delgado, Victoria, Freemantle, Nick, Gilard, Martine, Haugaa, Kristina H., Jeppsson, Anders, Jüni, Peter, Pierard, Luc, Prendergast, Bernard D., Sadaba, J. Rafael, Tribouilloy, Christophe, Wojakowski, Wojtek, Neumann, Franz-Josef, Myers, Patrick, Abdelhamid, Magdy, Achenbach, Stephan, Asteggiano, Riccardo, Barili, Fabio, Borger, Michael A., Carrel, Thierry, Collet, Jean-Philippe, Foldager, Dan, Habib, Gilbert, Hassager, Christian, Irs, Alar, Iung, Bernard, Jahangiri, Marjan, Katus, Hugo A., Koskinas, Konstantinos C., Massberg, Steffen, Mueller, Christian E., Nielsen, Jens Cosedis, Pibarot, Philippe, Rakisheva, Amina, Roffi, Marco, Rubboli, Andrea, Shlyakhto, Evgeny, Siepe, Matthias, Sitges, Marta, Sondergaard, Lars, Sousa-Uva, Miguel, Tarantini, Guiseppe, Zamorano, Jose Luis, Benchabi, Yasmina, Chilingaryan, Aram, Metzler, Bernhard, Rustamova, Yasmin, Shumavets, Vadim, Lancellotti, Patrizio, Smajic, Elnur, Trendafilova-Lazarova, Diana, Samardzic, Jure, Karakyriou, Maria, Palecek, Tomas, Dahl, Jordi Sanchez, Meshaal, Marwa Sayed, Palm, Kairit, Virtanen, Marko, Bouleti, Claire, Bakhutashvili, Zviad, Boutsikou, Maria, Kertész, Attila B. la, Danielsen, Ragnar, Topilsky, Yan, Golino, Paolo, Tuleutayev, Rustem, Elezi, Shpend, Kerimkulova, Alina, Rudzitis, Ainars, Glaveckaite, Sigita, Sow, Rouguiatou, Demarco, Daniela Cassar, Bulatovic, Nebojsa, Aouad, Aicha, van den Brink, Renée, Antova, Emilija, Beitnes, Jan Otto, Ochala, Andrzej, Ribeiras, Regina, Vinereanu, Dragos, Irtyuga, Olga, Ivanovic, Branislava, Simkova, Iveta, Gomez, Ariana Gonzalez, Sarno, Giovanna, Pedrazzini, Giovanni B., Bsata, Walid, Zakhama, Lilia, Korkmaz, Levent, Cherniuk, Sergii, Khanji, Mohammed Y., Sharipov, Islamjan, Baigent, Colin, Aboyans, Victor, Antoniou, Sotiris, Arbelo, Elena, Baumbach, Andreas, Čelutkiene, Jelena, Cikes, Maja, Falk, Volkmar, Fauchier, Laurent, Gale, Chris P., Halvorsen, Sigrun, Jaarsma, Tiny, Konradi, Aleksandra, Kotecha, Dipak, Landmesser, Ulf, Lewis, Basil S., Linhart, Ales, Løchen, Maja-Lisa, Neubeck, Lis, Petersen, Steffen E., Prescott, Eva, Touyz, Rhian M., Galletti, Lorenzo, Hazekamp, Mark, Licht, Peter, Perier, Patrick, Prager, Richard, Roessner, Eric, Tsagakis, Konstantinos, Zientara, Alicja, Čelutkienė, Jelena, Glaveckaitė, Sigita, Vahanian, Alec, Beyersdorf, Friedhelm, Praz, Fabien, Milojevic, Milan, Baldus, Stephan, Bauersachs, Johann, Capodanno, Davide, Conradi, Lenard, De Bonis, Michele, De Paulis, Ruggero, Delgado, Victoria, Freemantle, Nick, Gilard, Martine, Haugaa, Kristina H, Jeppsson, Ander, Jüni, Peter, Pierard, Luc, Prendergast, Bernard D, Sádaba, J Rafael, Tribouilloy, Christophe, Wojakowski, Wojtek, Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., de Bonis, M., de Paulis, R., Delgado, V., Freemantle, N., Gilard, M., Haugaa, K. H., Jeppsson, A., Juni, P., Pierard, L., Prendergast, B. D., Sadaba, J. R., Tribouilloy, C., Wojakowski, W., Cardiology, and ACS - Amsterdam Cardiovascular Sciences

Subjects
Pulmonary and Respiratory Medicine, medicine.medical_specialty, Valve surgery, valve surgery, aortic regurgitation, aortic stenosis, Guidelines, mitral regurgitation, mitral stenosis, percutaneous valve intervention, prosthetic heart valves, tricuspid regurgitation, tricuspid stenosis, valve disease, valvular heart disease, Cardiology, Heart Valve Diseases, Tricuspid stenosis, Mitral valve stenosis, Tricuspid Valve Insufficiency, Internal medicine, Myocardial Revascularization, Medicine, Humans, 610 Medicine & health, Heart Valve Prosthesis Implantation, Mitral regurgitation, business.industry, Mitral Valve Insufficiency, General Medicine, medicine.disease, Aortic valve stenosis, Surgery, Cardiology and Cardiovascular Medicine, business, Valve disease
Published
2021

16. European society of cardiology

Author

Timmis, Adam, Townsend, Nick, Gale, Chris P., Torbica, Aleksandra, Lettino, Maddalena, Petersen, Steffen E., Mossialos, Elias A., Maggioni, Aldo P., Kazakiewicz, Dzianis, May, Heidi T, De Smedt, Delphine, Flather, Marcus, Zuhlke, Liesl, Beltrame, John F., Huculeci, Radu, Tavazzi, Luigi, Hindricks, Gerhard, Bax, Jeroen, Casadei, Barbara, Achenbach, Stephan, Wright, Lucy, Vardas, Panos, Mimoza, Lezha, Artan, Goda, Aurel, Demiraj, Chettibi, Mohammed, Hammoudi, Naima, Sisakian, Hamayak, Pepoyan, Sergey, Metzler, Bernhard, Siostrzonek, Peter, Weidinger, Franz, Jahangirov, Tofig, Aliyev, Farid, Rustamova, Yasmin, Manak, Nikolay, Mrochak, Aliaksandr, Lancellotti, Patrizio, Pasquet, Agnès, Claeys, Marc, Kušljugić, Zumreta, Dizdarević Hudić, Larisa, Smajić, Elnur, Tokmakova, Mariya Petkova, Gatzov, Plamen Marinov, Milicic, Davor, Bergovec, Mijo, Christou, Christos, Moustra, Hera Heracleous, Christodoulides, Theodoros, Linhart, Ales, Taborsky, Milos, Hansen, Henrik Steen, Holmvang, Lene, Kristensen, Steen Dalby, Abdelhamid, Magdy, Shokry, Khaled, Kampus, Priit, Viigimaa, Margus, Ryödi, Essi, Niemelä, Matti, Rissanen, Tuomas T., Le Heuzey, Jean-Yves, Gilard, Martine, Aladashvili, A., Gamkrelidze, A., Kereselidze, Maia, Zeiher, A., Katus, H., Bestehorn, K., Tsioufis, Costas, Goudevenos, John, Csanádi, Zoltán, Becker, Dávid, Tóth, Kálmán, Jóna Hrafnkelsdóttir, Þórdís, Crowley, James, Kearney, Peter, Dalton, Barbra, Zahger, Doron, Wolak, Arik, Gabrielli, Domenico, Indolfi, Ciro, Urbinati, Stefano, Imantayeva, Gulnara, Berkinbayev, Salim, Bajraktari, Gani, Ahmeti, Artan, Berisha, Gezim, Erkin, Mirrakhimov, Saamay, Abilova, Erglis, Andrejs, Bajare, Iveta, Jegere, Sanda, Mohammed, Malek, Sarkis, Antoine, Saadeh, Georges, Zvirblyte, Ruta, Sakalyte, Gintare, Slapikas, Rimvydas, Ellafi, Khaled, El Ghamari, Fathi, Banu, Cristiana, Beissel, Jean, Felice, Tiziana, Buttigieg, Sandra C, Xuereb, Robert G., Popovici, Mihail, Boskovic, Aneta, Rabrenovic, Miroslav, Ztot, Samir, Abir-khalil, Saadia, van Rossum, A. C., Mulder, B. J. M., Elsendoorn, M. W., Srbinovska-Kostovska, Elizabeta, Kostov, Jorgo, Marjan, Bosevski, Steigen, Terje, Mjølstad, Ole Christian, Ponikowski, Piotr, Witkowski, Adam, Jankowski, Piotr, Gil, Victor Machado, Mimoso, Jorge, Baptista, Sérgio, Vinereanu, Dragos, Chioncel, Ovidiu, Popescu, Bogdan A., Shlyakhto, Evgeny, Oganov, Raphael, Foscoli, Marina, Zavatta, Marco, Dikic, Ana Djordjevic, Beleslin, Branko, Radovanovic, Mina Radosavljevic, Hlivák, Peter, Hatala, Robert, Kaliská, Gabriela, Kenda, Miran, Fras, Zlatko, Anguita, Manuel, Cequier, Ángel, Muñiz, Javier, James, Stefan, Johansson, Bengt, Platonov, Pyotr, Zellweger, Michael Johannes, Pedrazzini, Giovanni B., Carballo, David, Shebli, Hussam Eddin, Kabbani, Samer, Abid, Leila, Addad, Faouzi, Bozkurt, Engin, Kayıkçıoğlu, Meral, Erol, Mustafa Kemal, Kovalenko, Volodymyr, Nesukay, Elena, Wragg, Andrew, Ludman, Peter, Ray, Simon, Kurbanov, Ravshanbek, Boateng, Dennis, Daval, Ghislain, De Benito Rubio, Víctor, Sebastiao, David, De Courtelary, Paola Thellung, Bardinet, Isabel, Cardiology, ACS - Heart failure & arrhythmias, APH - Personalized Medicine, and APH - Aging & Later Life

Subjects
Male, medicine.medical_specialty, Mortality • morbidity, Health infrastructure, Cardiology, Disease, 030204 cardiovascular system & hematology, European Society of Cardiology, 03 medical and health sciences, 0302 clinical medicine, CARDIOVASCULAR DISEASE, EUROPEAN SOCIETY OF CARDIOLOGY, HEALTH INFRASTRUCTURE, MORBIDITY, MORTALITY, RISK FACTORS, SERVICE PROVISION, STATISTICS, Interquartile range, Internal medicine, Statistics, medicine, Humans, 030212 general & internal medicine, Myocardial infarction, Service provision, Mortality, Disease burden, business.industry, medicine.disease, Cardiovascular disease, Obesity, Europe, Years of potential life lost, Risk factors, Cardiovascular Diseases, Hypertension, Income, Female, Population Risk, Morbidity, Cardiology and Cardiovascular Medicine, business, Body mass index
Abstract

Aims The 2019 report from the European Society of Cardiology (ESC) Atlas provides a contemporary analysis of cardiovascular disease (CVD) statistics across 56 member countries, with particular emphasis on international inequalities in disease burden and healthcare delivery together with estimates of progress towards meeting 2025 World Health Organization (WHO) non-communicable disease targets. Methods and results In this report, contemporary CVD statistics are presented for member countries of the ESC. The statistics are drawn from the ESC Atlas which is a repository of CVD data from a variety of sources including the WHO, the Institute for Health Metrics and Evaluation, and the World Bank. The Atlas also includes novel ESC sponsored data on human and capital infrastructure and cardiovascular healthcare delivery obtained by annual survey of the national societies of ESC member countries. Across ESC member countries, the prevalence of obesity (body mass index ≥30 kg/m2) and diabetes has increased two- to three-fold during the last 30 years making the WHO 2025 target to halt rises in these risk factors unlikely to be achieved. More encouraging have been variable declines in hypertension, smoking, and alcohol consumption but on current trends only the reduction in smoking from 28% to 21% during the last 20 years appears sufficient for the WHO target to be achieved. The median age-standardized prevalence of major risk factors was higher in middle-income compared with high-income ESC member countries for hypertension {23.8% [interquartile range (IQR) 22.5–23.1%] vs. 15.7% (IQR 14.5–21.1%)}, diabetes [7.7% (IQR 7.1–10.1%) vs. 5.6% (IQR 4.8–7.0%)], and among males smoking [43.8% (IQR 37.4–48.0%) vs. 26.0% (IQR 20.9–31.7%)] although among females smoking was less common in middle-income countries [8.7% (IQR 3.0–10.8) vs. 16.7% (IQR 13.9–19.7%)]. There were associated inequalities in disease burden with disability-adjusted life years per 100 000 people due to CVD over three times as high in middle-income [7160 (IQR 5655–8115)] compared with high-income [2235 (IQR 1896–3602)] countries. Cardiovascular disease mortality was also higher in middle-income countries where it accounted for a greater proportion of potential years of life lost compared with high-income countries in both females (43% vs. 28%) and males (39% vs. 28%). Despite the inequalities in disease burden across ESC member countries, survey data from the National Cardiac Societies of the ESC showed that middle-income member countries remain severely under-resourced compared with high-income countries in terms of cardiological person-power and technological infrastructure. Under-resourcing in middle-income countries is associated with a severe procedural deficit compared with high-income countries in terms of coronary intervention, device implantation and cardiac surgical procedures. Conclusion A seemingly inexorable rise in the prevalence of obesity and diabetes currently provides the greatest challenge to achieving further reductions in CVD burden across ESC member countries. Additional challenges are provided by inequalities in disease burden that now require intensification of policy initiatives in order to reduce population risk and prioritize cardiovascular healthcare delivery, particularly in the middle-income countries of the ESC where need is greatest.

Published
2020

21. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life.

Author

Shchendrygina A, Rakisheva A, Giverts I, Rustamova Y, and Soloveva A

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are emerging glucose-lowering agents primarily used in managing diabetes and obesity. Recently, GLP-1 RAs have garnered attention for their cardiovascular benefits beyond glycaemic control in patients with type 2 diabetes, exhibiting patterns previously seen in cardiovascular outcomes trials on sodium-glucose cotransporter 2 inhibitors, which now receive a high level of recommendation for the treatment of heart failure (HF). GLP-1 RAs have been increasingly investigated in HF cohorts, but mainly in small-scale studies reporting inconclusive findings regarding clinical outcomes and different safety profiles in HF patients with reduced and preserved ejection fractions. This review discusses the effects of GLP-1 RAs on surrogate HF outcomes, such as cardiac structure and function, exercise capacity and quality of life, in HF patients across the spectrum of left ventricular ejection fraction, to provide insights into the potential of these agents to be investigated in large clinical trials to evaluate clinical outcomes., Competing Interests: Disclosure: AR reports receiving speaker fees from Novartis, Roche Diagnostics and AstraZeneca, and is on the Cardiac Failure Review editorial board; this did not influence peer review. A Soloveva has received grants from the European Society of Cardiology and support from AstraZeneca, Bayer, Novartis and Servier. All other authors have no conflicts of interest to declare., (Copyright © The Author(s), 2024. Published by Radcliffe Group Ltd.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results